Floatz logo

MAGNESIUM METALLICUM

Anemia, Sickle Cell

Medical College of WisconsinSmall moleculePhase 3Dormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
89/ 100

Competitive context

135 Active assets in the Anemia, Sickle Cell cohort.

Asset / SponsorPhaseRating
Glutamine
Ain Shams University
Phase 4BBB
Hydroxyurea
St. Jude Children's Research Hospital
Phase 4BB
Crizanlizumab
Novartis Pharmaceuticals
Phase 4BB
FILGRASTIM
St. Jude Children's Research Hospital
Phase 4BB
NEPENTHE
Oman Medical Speciality Board
Phase 4BB

View all 50 →

Same molecule, other indications

MAGNESIUM METALLICUM is also rated in:

Alcohol WithdrawalDormant
BB
Indicative ·
70 / 100
View asset →
Pre-eclampsiaDormant
BB
Indicative ·
68 / 100
View asset →
Brain InjuriesDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →